Evaluation of gamma interferon (IFN-γ)-induced protein 10 responses for detection of cattle infected with Mycobacterium bovis: Comparisons to IFN-γ responses

Clinical and Vaccine Immunology

Volumn 19, Issue 3, 2012, Pages 346-351

  Waters, W R ^a   Thacker, T C ^a   Nonnecke, B J ^a   Palmer, M V ^a   Schiller, I ^b   Oesch, B ^c   Vordermeier, H M ^d   Silva, E ^e   Estes, D M ^f  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

^b SWISS FEDERAL VETERINARY OFFICE   (Switzerland)

^c NEUROTUNE AG   (Switzerland)

^d VETERINARY LABORATORIES AGENCY   (United Kingdom)

^e Veterinary Dentistry and Oral Surgery   (United States)

^f UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL RNA; BIOLOGICAL MARKER; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MESSENGER RNA; MYCOBACTERIUM ANTIGEN; TUBERCULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BOVINE TUBERCULOSIS; CATTLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE MARKER; GENE EXPRESSION REGULATION; GENE EXPRESSION SYSTEM; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CATTLE; CHEMOKINE CXCL10; GENE EXPRESSION PROFILING; INTERFERON-GAMMA; MALE; MYCOBACTERIUM BOVIS; STATISTICS AS TOPIC; TUBERCULOSIS, BOVINE;

EID: 84857964949     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05657-11     Document Type: Article

References (34)

1. Aabye MG, et al. 2010. Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients. Eur. Respir. J. 36:1488-1490.
2. Aabye MG, Ravn P, Johansen IS, Eugen-Olsen J, Ruhwald M. 2011. Incubation of whole blood at 39°C augments gamma interferon (IFN-γ)- induced protein 10 and IFN-γ responses to Mycobacterium tuberculosis antigens. Clin. Vaccine Immunol. 18:1150-1156.
3. Alvarez A, Endsley JJ, Werling D, Estes DM. 2009. WC1(+) gammadelta T cells indirectly regulate chemokine production during Mycobacterium bovis infection in SCID-bo mice. Transbound. Emerg. Dis. 56:275-284.
4. Azzurri A, et al. 2005. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect. 7:1-8. (Pubitemid 40431338)
5. Blanco FC, et al. 2011. Increased IL-17 expression is associated with pathology in a bovine model of tuberculosis. Tuberculosis (Edinb.) 91:57-63.
6. Cole AM, et al. 2001. IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J. Immunol. 167:623-627. (Pubitemid 32660811)
7. Cousins DV, et al. 2003. Tuberculosis in seals caused by a novel member of the Mycobacterium tuberculosis complex: Mycobacterium pinnipedii sp. nov. Int. J. Syst. Evol. Microbiol. 53:1305-1314. (Pubitemid 37184959)
8. Farber JM. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol. 61:246-257. (Pubitemid 27149903)
9. Ferrero E, et al. 2003. Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on gammadelta cells. Immunology 108:365-374. (Pubitemid 36332395)
10. Geluk A, et al. 2010. Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays. Clin. Vaccine Immunol. 17:993-1004.
11. Jones GJ, Pirson C, Hewinson RG, Vordermeier HM. 2010. Simultaneous measurement of antigen-stimulated interleukin-1 beta and gamma interferon production enhances test sensitivity for the detection of Mycobacterium bovis infection in cattle. Clin. Vaccine Immunol. 17:1946-1951.
12. Juffermans NP, et al. 1999. Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan. Infect. Immun. 67:4295- 4297.
13. Kabeer BS, Sikhamani R, Raja A. 2010. Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients. AIDS 24:323-325.
14. Kaplan G, Luster AD, Hancock G, Cohn ZA. 1987. The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin. J. Exp. Med. 166:1098-1108. (Pubitemid 18024249)
15. Kasprowicz VO, et al. 2011. A molecular assay for sensitive detection of pathogen-specific T-cells. PLoS One 6:e20606.
16. Palmer MV, Waters WR, Whipple DL. 2003. Aerosol delivery of virulent Mycobacterium bovis to cattle. Tuberculosis (Edinb.) 82:275-282.
17. Ruhwald M, et al. 2011. A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb.) 91:260-267.
18. Ruhwald M, Bjerregaard-Andersen M, Rabna P, Eugen-Olsen J, Ravn P. 2009. IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay. BMC Res. Notes 2:19.
19. Ruhwald M, et al. 2008. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur. Respir. J. 32:1607-1615.
20. Ruhwald M, et al. 2007. CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect. 9:806-812. (Pubitemid 46901043)
21. Sauty A, et al. 1999. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J. Immunol. 162:3549-3558. (Pubitemid 29313608)
22. Schiller I. et al. 2011. Bovine tuberculosis in Europe from the perspective of an OTF country: trade, surveillance and diagnostics. Vet. Microbiol. 151:153-159.
23. Schiller I, et al. 2010. Bovine tuberculosis: a review of current and emerging diagnostic techniques in view of their relevance for disease control and eradication. Transbound. Emerg. Dis. 57:205-220.
24. Schiller I, et al. 2009. Assessment of OmpA as a novel antigen for the diagnosis of bovine tuberculosis. Clin. Vaccine Immunol. 16:1314-1321.
25. Scollard DM, et al. 2011. Increased CXC ligand 10 levels and gene expression in type 1 leprosy reactions. Clin. Vaccine Immunol. 18:947-953.
26. Stefani MM, et al. 2009. Potential plasma markers of type 1 and type 2 leprosy reactions: a preliminary report. BMC Infect. Dis. 9:75.
27. Taubert A, Behrendt JH, Sühwold A, Zahner H, Hermosilla C. 2009. Monocyte- and macrophage-mediated immune reactions against Eimeria bovis. Vet. Parasitol. 164:141-153.
28. Thacker TC, Palmer MV, Waters WR. 2006. Correlation of cytokine gene expression with pathology in white-tailed deer (Odocoileus virginianus) infected with Mycobacterium bovis. Clin. Vaccine Immunol. 13:640-647. (Pubitemid 44032508)
29. Thacker TC, Palmer MV, Waters WR. 2007 Associations between cytokine gene expression and pathology in Mycobacterium bovis infected cattle. Vet. Immunol. Immunopathol. 119:204-213. (Pubitemid 47368668)
30. Vordermeier HM, et al. 2009. Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect. Immun. 77:3364 -3373. (Erratum, 79:2134, 2011.)
31. Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A. 2011. Immunological biomarkers of tuberculosis. Nat. Rev. Immunol. 11:343-354.
32. Waters WR, Palmer MV, Whipple DL, Carlson MC, Nonnecke BJ. 2003. Diagnostic implications of antigen-induced IFN-γ, nitric oxide, and TNF-α production by blood mononuclear cells from Mycobacterium bovis-infected cattle. Clin. Diagn. Lab. Immunol. 10:960-966. (Pubitemid 37129514)
33. Waters WR, et al. 2010. Immune responses in cattle inoculated with Mycobacterium bovis, Mycobacterium tuberculosis, or Mycobacterium kansasii. Clin. Vaccine Immunol. 17:247-252.
34. Whittaker E, Gordon A, Kampmann B. 2008. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFN gamma? PLoS One 3:e3901.